COVID-19 vaccinology landscape in Africa

Show simple item record

dc.contributor.author Baptista, Sara
dc.contributor.author Naidoo, Sanushka
dc.contributor.author Suliman, Sara
dc.contributor.author Nepolo, Emmanuel
dc.contributor.author Kanoi, Bernard N.
dc.contributor.author Gitaka, Jesse
dc.contributor.author Blessing, Oyedemi Mbaebie
dc.contributor.author Enany, Shymaa
dc.date.accessioned 2023-07-05T05:06:58Z
dc.date.available 2023-07-05T05:06:58Z
dc.date.issued 2022-12-05
dc.description.abstract More than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the continent. This opinion discusses the challenges Africa faces in its race to vaccinate its people, and offers recommendations on the way forward. Specifically, to get out of the ongoing vaccine shortage trap, Africa needs to diversify investment not only to COVID-19 but also other diseases that burden the population. The continent needs to increase its capacity to acquire vaccines more equitably, improve access to technologies to enable local manufacture of vaccines, increase awareness on vaccines both in rural and urban areas to significantly reduce disease incidence of COVID-19 and as well as other prevalent diseases on the African continent such as HIV and TB. Such efforts will go a long way to reduce the disease burden in Africa. en_US
dc.description.department Biochemistry en_US
dc.description.department Forestry and Agricultural Biotechnology Institute (FABI) en_US
dc.description.department Genetics en_US
dc.description.department Microbiology and Plant Pathology en_US
dc.description.librarian am2023 en_US
dc.description.sponsorship The Massachusetts Life Sciences Center Accelerating Coronavirus Testing Solutions, Nina Ireland Program for Lung Health, the Chan Zuckerberg Biohub Initiative and Africa Academy of Sciences funding for COVID-19 Research & Development goals for Africa. en_US
dc.description.uri https://www.frontiersin.org/journals/immunology en_US
dc.identifier.citation Baptista, S., Naidoo, S., Suliman, S., Nepolo, E., Kanoi, B.N., Gitaka, J., Blessing, O.M. & Enany, S. (2022) COVID-19 vaccinology landscape in Africa. Frontiers in Immunology 13:955168. DOI: 10.3389/fimmu.2022.955168. en_US
dc.identifier.issn 1664-3224 (online)
dc.identifier.other 10.3389/fimmu.2022.955168
dc.identifier.uri http://hdl.handle.net/2263/91264
dc.language.iso en en_US
dc.publisher Frontiers Media en_US
dc.rights © 2022 Baptista, Naidoo, Suliman, Nepolo, Kanoi, Gitaka, Blessing and Enany. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). en_US
dc.subject Vaccinology en_US
dc.subject Africa en_US
dc.subject Local manufacture en_US
dc.subject Improved access en_US
dc.subject Vaccines en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title COVID-19 vaccinology landscape in Africa en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record